Nothing Special   »   [go: up one dir, main page]

TR201910280T4 - Mastitin tedavisine yönelik Lactobacillus salivarius. - Google Patents

Mastitin tedavisine yönelik Lactobacillus salivarius. Download PDF

Info

Publication number
TR201910280T4
TR201910280T4 TR2019/10280T TR201910280T TR201910280T4 TR 201910280 T4 TR201910280 T4 TR 201910280T4 TR 2019/10280 T TR2019/10280 T TR 2019/10280T TR 201910280 T TR201910280 T TR 201910280T TR 201910280 T4 TR201910280 T4 TR 201910280T4
Authority
TR
Turkey
Prior art keywords
treatment
lactobacillus salivarius
mastitis
breast
infection
Prior art date
Application number
TR2019/10280T
Other languages
English (en)
Inventor
Martin Rocio
Knol Jan
Fernández Álvarez Leonides
Espinosa Martos Irene
Antonia Jiménez Quintana Esther
Miguel Rodriguez Gómez Juan
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of TR201910280T4 publication Critical patent/TR201910280T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Buluş, Lactobacillus salivarius'un bir yeni suşu, yeni suşu içeren ürünler, memedeki veya meme dokusundaki, özel olarak bir dişi insanın bir mamari bezdeki, enflamasyonun ve/veya enfeksiyonun tedavisinde ve/veya önlenmesinde bunların kullanımı ve memedeki veya meme dokusundaki, özel olarak bir dişi insanın bir mamari bezdeki, enflamasyonun ve/veya enfeksiyonun tedavisi ve/veya önlenmesi için yöntemler ile ilgilidir.
TR2019/10280T 2013-12-19 2014-12-19 Mastitin tedavisine yönelik Lactobacillus salivarius. TR201910280T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2013/050924 WO2015093937A1 (en) 2013-12-19 2013-12-19 Lactobacillus salivarius for the treatment of mastitis

Publications (1)

Publication Number Publication Date
TR201910280T4 true TR201910280T4 (tr) 2019-07-22

Family

ID=50001228

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/10280T TR201910280T4 (tr) 2013-12-19 2014-12-19 Mastitin tedavisine yönelik Lactobacillus salivarius.

Country Status (15)

Country Link
US (1) US10420807B2 (tr)
EP (1) EP3084009B1 (tr)
CN (1) CN106103695B (tr)
AU (1) AU2014367412B2 (tr)
DK (1) DK3084009T3 (tr)
ES (1) ES2734204T3 (tr)
HU (1) HUE044330T2 (tr)
MY (1) MY186323A (tr)
NZ (1) NZ720901A (tr)
PH (1) PH12016501087A1 (tr)
PL (1) PL3084009T3 (tr)
PT (1) PT3084009T (tr)
RU (1) RU2684600C1 (tr)
TR (1) TR201910280T4 (tr)
WO (2) WO2015093937A1 (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109310705A (zh) * 2016-03-18 2019-02-05 加拿大农业及农业食品部 干奶时加速乳腺退化和预防乳腺感染的方法
EP3517119B1 (en) 2018-01-26 2021-08-11 Probisearch, S.L.U. Composition comprising new lactobacillus salivarius strain and method for the prevention and treatment of otitis and upper respiratory infections
RU2709970C1 (ru) * 2019-07-05 2019-12-23 Илья Владимирович Кукес Способ лечения и профилактики острых и хронических форм мастита у животных
WO2021095476A1 (ja) * 2019-11-11 2021-05-20 株式会社ヤクルト本社 オリゴ糖を含む発酵乳の製造方法
CN115725443B (zh) * 2019-11-14 2024-07-05 内蒙古蒙牛乳业（集团）股份有限公司 一株鼠李糖乳杆菌及其应用
EP4065146A1 (en) * 2019-11-29 2022-10-05 Société des Produits Nestlé S.A. Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis
CA3161666A1 (en) * 2019-11-29 2021-06-03 Societe Des Produits Nestle S.A. Compositions and methods for the treatment of mastitis
RU2726653C2 (ru) * 2019-12-26 2020-07-15 Федеральное государственное бюджетное учреждение науки Оренбургский федеральный исследовательский центр Уральского отделения Российской академии наук Штамм бактерий Lactobacillus salivarius - продуцент ингибитора цитокинов интерлейкина-6 и интерлейкина-17
US20230040010A1 (en) * 2020-01-16 2023-02-09 Societe Des Produits Nestle S.A. Compositions and methods for the treatment of mastitis
CN113981116A (zh) * 2021-11-30 2022-01-28 广州舒客实业有限公司 用于快速鉴定唾液乳杆菌的特异性引物、试剂盒及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1565547T4 (da) * 2002-06-28 2013-01-14 Biosearch S A Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
EP2551279A1 (en) * 2011-07-27 2013-01-30 University College Cork Antimicrobial peptide produced by intestinal Lactobacillus salivarius

Also Published As

Publication number Publication date
AU2014367412B2 (en) 2021-03-11
ES2734204T3 (es) 2019-12-04
NZ720901A (en) 2022-11-25
HUE044330T2 (hu) 2019-10-28
EP3084009B1 (en) 2019-04-10
DK3084009T3 (da) 2019-07-15
PH12016501087B1 (en) 2016-07-11
PH12016501087A1 (en) 2016-07-11
RU2684600C1 (ru) 2019-04-09
EP3084009A1 (en) 2016-10-26
US20170027997A1 (en) 2017-02-02
US10420807B2 (en) 2019-09-24
MY186323A (en) 2021-07-09
WO2015093937A1 (en) 2015-06-25
WO2015093963A1 (en) 2015-06-25
RU2016129178A (ru) 2018-01-24
AU2014367412A1 (en) 2016-07-07
CN106103695B (zh) 2020-12-01
PL3084009T3 (pl) 2019-09-30
CN106103695A (zh) 2016-11-09
PT3084009T (pt) 2019-07-17

Similar Documents

Publication Publication Date Title
TR201910280T4 (tr) Mastitin tedavisine yönelik Lactobacillus salivarius.
MX2016005585A (es) Exopolisacarido para el tratamiento y/o el cuidado de la piel, medios de cultivo y composiciones del mismo.
UY36701A (es) Tratamiento contra el cáncer por manipulación de la microflora comensal
MD4733C1 (ro) Anticorpi anti-TIGIT
EA201792547A1 (ru) Популяции бактерий для стимуляции состояния здоровья
MX366205B (es) Heterociclos capaces de modular las respuestas de los linfocitos t, y métodos de uso de los mismos.
MX2015002289A (es) Anticuerpos humanos para gfr alfa 3 y métodos para su uso.
AR101072A1 (es) Extracto de fermento de una cepa bacteriana para el aumento de los niveles de adiponectina
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
MX370958B (es) Uso de alquilamidotiazoles en preparaciones cosméticas o dermatológicas para la profilaxis y el tratamiento de piel sensible.
MX2023010501A (es) Profarmacos de dantroleno y metodos de su uso.
MA40535A (fr) Imagerie et thérapie d'une inflammation et d'une infection ciblant hsp90
MX2013007995A (es) Peptidos derivados de lactoferrina humana y su uso.
GB2558315A (en) Patterned surfaces
MX2017005812A (es) Composiciones de limpieza.
MX2018008640A (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano.
NZ729181A (en) Treatment of disease with poly-n-acetylglucosamine nanofibers
UA113399C2 (xx) Штам непатогенної грамнегативної бактерії та його застосування в дерматології
MX364528B (es) Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas.
WO2013162981A3 (en) Breast implant spacers for the treatment of periprosthetic breast implant infections
PH12016501179B1 (en) Composition
AR096754A1 (es) Composición de solución de rehidratación oral que contiene probióticos
NZ629711A (en) Anti-inflammatory compositions, methods and uses thereof
UA99313U (uk) Композиція інгредієнтів для оздоровчого засобу з природними цілющими властивостями "секрет жіночої краси"
RU2015118637A (ru) Тени бактерий L. delbrueckii 76 для стимулирования врожденного иммунного ответа и их применение